DBV Technologies DBVT
NASDAQ DBVT
$13.56 -0.14 (-0.99%)
As of: Sep 4, 2026 · 3:15 PM EDT

DBV Technologies (DBVT) Other Accumulated Expenses (2019 - 2026)

DBV Technologies (DBVT) posted Other Accumulated Expenses of $13.8 million for Q2 2026, up 27.78% sequentially from $10.8 million in Q1 2026, and up 83.56% YoY from $7.5 million in Q2 2025.

Analysis

DBV Technologies (DBVT) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

DBV Technologies has reported Other Accumulated Expenses for 8 years, with the latest figure at $13.8 million in Q2 2026.

  • Quarterly Other Accumulated Expenses rose 83.56% year-over-year to $13.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $13.8 million (up 83.56% YoY) and the FY2025 annual result came in at $15.8 million, up 89.72% from the prior year.
  • Other Accumulated Expenses advanced to $13.8 million in Q2 2026 per DBVT's latest filing, from $10.8 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $15.8 million in Q4 2025 and troughed at $5.0 million in Q1 2024.
  • A 5-year average of $8.7 million and a median of $8.5 million in 2022 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2022 and 2026: Other Accumulated Expenses sank 34.9% in 2022, then soared 98.27% in 2026.
  • Over 5 years, Other Accumulated Expenses stood at $9.2 million in 2022, then slipped by 3.0% to $8.9 million in 2023, then slipped by 6.78% to $8.3 million in 2024, then surged by 89.72% to $15.8 million in 2025, then decreased by 12.66% to $13.8 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $13.8 million, $10.8 million, and $15.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.43 Bn 130.58 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.34 Bn 58.15 Bn 1.37 Bn
4 Moderna 57.98 Bn 52.85 Bn 52.00 Mn
5 Revolution Medicines 43.98 Bn 43.98 Bn -
6 BeOne Medicines 39.92 Bn 34.82 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.42 Bn 32.11 Bn 992.69 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn -
9 Insmed 27.36 Bn 26.20 Bn 358.27 Mn
10 DBV Technologies 5.88 Bn 5.71 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.80 Mn
Mar 31, 2026 10.80 Mn
Dec 31, 2025 15.80 Mn
Sep 30, 2025 8.45 Mn
Jun 30, 2025 7.52 Mn
Mar 31, 2025 5.45 Mn
Dec 31, 2024 8.33 Mn
Sep 30, 2024 7.79 Mn
Jun 30, 2024 6.16 Mn
Mar 31, 2024 5.02 Mn
Dec 31, 2023 8.93 Mn
Sep 30, 2023 8.67 Mn
Jun 30, 2023 7.26 Mn
Mar 31, 2023 6.78 Mn
Dec 31, 2022 9.21 Mn
Sep 30, 2022 8.62 Mn
Jun 30, 2022 8.78 Mn
Mar 31, 2022 8.72 Mn
Dec 31, 2021 12.36 Mn
Sep 30, 2021 12.66 Mn